Hyperhomocysteinaemia-induced cardiovascular changes in rats

Leonardo B M Resstel1, Claudia R de Andrade, Renato Haddad

  • 1Department of Pharmacology, School of Medicine, University of São Paulo, Ribeiraão Preto, Brazil.

Insights

Elevated homocysteine (HHcys) in rats increased blood pressure, heart rate, and baroreflex activity. These cardiovascular changes were reversible, indicating moderate HHcys impacts cardiovascular function.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Background:

  • Elevated plasma homocysteine is linked to increased cardiovascular risks.
  • Hyperhomocysteinaemia (HHcys) may affect cardiovascular system activity.
  • Understanding HHcys effects on cardiovascular function is crucial for risk assessment.

Purpose of the Study:

  • To investigate the impact of moderate HHcys on cardiovascular system activity in rats.
  • To determine the effects of HHcys on arterial blood pressure, heart rate, baroreflex, and vascular reactivity.
  • To explore the role of cardiac sympathetic activity in HHcys-induced hypertension.

Main Methods:

  • Male Wistar rats were treated with dl-homocysteine thiolactone (DL-HT) to induce moderate HHcys.
  • Cardiovascular parameters including arterial blood pressure, heart rate, and baroreflex gain were measured.
  • Vascular reactivity was assessed using pressor and depressor agents, with and without DL-HT washout.

Main Results:

  • Moderate HHcys significantly increased baseline arterial blood pressure, heart rate, and baroreflex gain.
  • Vascular responsiveness to phenylephrine, sodium nitroprusside, and acetylcholine was altered in HHcys rats.
  • HHcys-related hypertension was reversed by atenolol, suggesting increased cardiac sympathetic activity.

Conclusions:

  • Moderate HHcys induces significant cardiovascular changes, including hypertension and altered baroreflex activity.
  • HHcys affects vascular responsiveness and is associated with increased cardiac sympathetic activity.
  • The observed cardiovascular alterations are reversible upon cessation of DL-HT treatment.